LC/MS, LC/SQ
IndustriesPharma & Biopharma
ManufacturerShimadzu
Significance of the Study
Genotoxic impurities (GTIs) such as aryl sulfonate esters pose significant health risks due to their potential to damage DNA at very low concentrations. Accurate monitoring of these trace-level impurities in pharmaceuticals is essential to ensure patient safety and comply with regulatory standards.
Objectives and Study Overview
This study aims to develop and validate a novel method using the Shimadzu LCMS-2050 single quadrupole system for simultaneous determination of five genotoxic aromatic sulfonate impurities in drug substances. The focus is on achieving high sensitivity, specificity, and a wide linear range with minimal sample preparation.
Methodology and Instrumentation Used
The analysis was performed on a Shimadzu Nexera XR UHPLC system coupled to an LCMS-2050 with a heated DUIS source in positive SIM mode. Chromatographic separation employed a Shim-pack GISS C18 column (100 mm × 2.1 mm, 1.9 µm) with gradient elution of 5 mM ammonium formate in water (A) and methanol (B) at 0.3 mL/min, 40 °C, and 2 µL injection. SIM parameters targeted m/z 190.04, 204.06, 218.08, and 232.09 for the five sulfonates. Sample preparation involved dissolving 45 mg drug powder in methanol, ultrasonication, filtration through a 0.22 µm membrane, and dilution. Standards ranging from 5 to 500 µg/L were prepared for calibration.
Main Results and Discussion
· Specificity: SIM chromatograms of blank and standards showed no interference at target retention times.
· Linearity: Calibration curves exhibited excellent linearity (r² > 0.994) over 5–500 µg/L.
· Repeatability: RSD values for retention time and peak area at 10, 50, and 500 µg/L were below 0.12% and 5.26%, respectively.
· Recovery: Spiked samples at 0.22, 0.44, and 2.2 µg/g yielded recoveries between 100.5% and 115.3%, meeting pharmacopoeial criteria.
Benefits and Practical Applications of the Method
The proposed method offers:
- Simple and rapid sample preparation without derivatization.
- High sensitivity and specificity for trace-level GTIs.
- Wide dynamic range suitable for QC laboratories.
- Flow path switching to minimize contamination by the main drug matrix.
Future Trends and Opportunities
Potential developments include expanding the method to other classes of genotoxic impurities, integrating automated sample preparation, implementing high-throughput screening workflows, and combining with other detectors for comprehensive impurity profiling.
Conclusion
A robust single-quadrupole LC-MS method was established for the simultaneous quantification of five genotoxic aryl sulfonates in pharmaceuticals. The approach demonstrates simple pretreatment, excellent specificity, high accuracy, and broad applicability for routine safety assessment.
References
- Liu, T. Simultaneous Determination of Five Genotoxic Aryl Sulfonates in Pharmaceuticals by LCMS-2050. Shimadzu Application News, 2024.
- Pharmacopoeia of the People’s Republic of China, 2020 Edition.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.